Clinical Studies for new Dental Implants

Clinical Studies for new Dental Implants
June 2004
OsseoNews
In a special June issue of the Journal of Oral Implantology, clinical researchers published the findings of several studies concerning the Ankylos SynCone and Cercon abutments, oral implants that are used to simulate natural teeth for individuals who have experienced tooth loss.
By using SynCone prefabricated parts, Ankylos implants are responsible for greatly simplifying and accelerating dental and clinical procedures. Ankylos dramatically reduces the high costs associated with the complex dental technical fabrication of previous dental implants and is a much more reliable substitute for human teeth.
Paul Weigl, an assistant professor in the Department of Prosthetic Dentistry at Goeth-University in Frankfurt, Germany, reports that "The Ankylos implant, unlike other prosthetic oral devices, offers a precisely machined, tapered-cone abutment (Morse taper) connection. This tapered abutment connection provides high resistance to bending and rotational torque during clinical function which significantly reduces the possibilities of screw fracture or loosening."
Additionally, the high-precision fits of Ankylos implants eliminate micro-gaps and other imperfections, so the implants appear as if they were the patient's own teeth.
In his article, Professor Weigl states that "The clinical results of single tooth crowns borne on Ankylos implants in the lateral tooth region are excellent when compared with the high prosthetic complication rate with other systems. Abutment loosening occurred in only 1.3% of the 233 Ankylos implants studied."
Oral implants are commonly used to anchor various dental prostheses into the mouth. Although there are a variety of different implant systems, all are based on the principal that part of the implant (the abutment) anchors into the oral cavity to provide a support structure for a prosthetic tooth.
The FDA has already approved Ankylos implants for limited use in the United States, and the device is now awaiting full approval.